A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis
about
Pharmacological treatments for fatigue associated with palliative careCarnitine for fatigue in multiple sclerosisPharmacological treatments for fatigue associated with palliative careCarnitine for fatigue in multiple sclerosisCarnitine for fatigue in multiple sclerosisEfficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 studyFatigue Management in Multiple SclerosisThe Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigueFatigue associated with multiple sclerosis: diagnosis, impact and managementFatigue in multiple sclerosis: mechanisms, evaluation, and treatmentManagement of fatigue in persons with multiple sclerosis.Effects of multidisciplinary rehabilitation on chronic fatigue in multiple sclerosis: a randomized controlled trialFatigue in multiple sclerosis.Pharmacologic options for the management of multiple sclerosis symptoms.Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice.Fatigue and cancer: causes, prevalence and treatment approaches.Fatigue in multiple sclerosis: a rational approach to evaluation and treatment.Management of cancer-related fatigue.Treatment of symptoms in multiple sclerosis.Parkinson's disease and fatigue.Origin of fatigue in multiple sclerosis: review of the literature.Treatment of fatigue in multiple sclerosis: a systematic review of the literature.Effect of a Single Bout of Intermittent versus Continuous Walking on Perceptions of Fatigue in People with Multiple Sclerosis.Management options in multiple sclerosis-associated fatigue.Medical use of psychostimulants: an overview.Multiple sclerosis: symptomatic treatment.Alertness-enhancing drugs as a countermeasure to fatigue in irregular work hours.Modafinil for the treatment of fatigue in lung cancer: a pilot study.Pineal calcification and its relationship to the fatigue of multiple sclerosis.Characteristics of the formation of chronic fatigue syndrome and approaches to its treatment in young patients with focal brain damage.HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis.Methylphenidate in the management of asthenia in breast cancer patients treated with docetaxel: results of a pilot study.Health-related quality of life in secondary progressive multiple sclerosis.Immediate recovery of cognitive functions and resolution of fatigue by treatment with weak electromagnetic fields in a patient with multiple sclerosis.[Therapy of fatigue in multiple sclerosis : A treatment algorithm].
P2860
Q24187756-61B47C80-5DAB-4A1C-A7A8-0850E6A77E25Q24197748-0FA24DBA-9053-49AC-BB32-6C3D2DA378C5Q24236457-211F587A-1B56-4BFA-8DCF-C09C1731C5CEQ24240036-F28B7D0A-8129-442E-8321-F7626AB8EA36Q24242583-1B60472A-27DD-4879-9107-E6DBDF2FDCD3Q24672427-0380EA2D-AB8E-427D-AA5C-4015571E504AQ26752946-D2939812-9F1F-411B-B233-A9DFAAA874BFQ28073849-0675BD17-60A7-496F-89BA-94C5790C5D82Q28180100-B3D76C3F-6E06-4F4A-A200-23199DE46BFEQ34021881-BCEA69C2-8ED2-44F1-93E7-9C2A6AE18900Q34180567-57E647DF-5C85-446E-ABF0-1262D951B751Q34214944-04F42B90-F08B-4B01-A03D-013441F3E008Q34566468-C731EC59-6123-4B87-8799-96AE52F0B0BFQ34861395-AFC8D4D6-43F9-4B9F-974B-2DA3C86FD937Q35018491-3839365A-9BE3-41F5-A821-25DEF2AF5F30Q35828557-1185E8B5-4394-472B-BAF6-C7796FDE646DQ36060099-F442EEE4-8F68-462D-8A06-BADCE1FFD3A1Q36156911-2C1CB5C6-1321-4F68-ADD8-4B9482D4687AQ36474348-1D1AC01C-A7D8-4B41-B87A-9536D4D02155Q36666578-C12D70F9-E8E1-4DEE-8CAB-1F6238C40F4FQ36780439-077552FB-D6C6-40F9-9773-842FB3A6A491Q37100322-E4B8A593-7667-42B0-B3D6-F79892A97C60Q37442256-4B204C2A-8F05-42AF-8450-6BFA5AEF76E1Q37973392-7AF2D858-DA7F-4642-A646-2E467B0D3BACQ40468173-9A21F64A-66B0-4A1F-BC81-CD2E40147EF8Q40931554-900121DF-223C-4163-A77A-04C8B9E3A6BDQ41422767-0B53BF55-5CBE-48CA-8F72-7A32916AC2CFQ46095786-33E02565-C73A-4CBD-A814-93C1B7B39AA4Q48223363-6C6F80E3-A24E-48D8-AE28-4F94A4719CA3Q48275804-D7B5FC80-033E-4281-80CC-AB288716B572Q48303575-A71C881B-75A8-47B6-B61A-2F08E3D10A4BQ48340615-EBB6CBDD-27B8-4E99-8E87-C5DBAE4A6100Q48471623-FF0DBEE2-AB7F-49E9-A0A6-D8CFE1E2D462Q52000784-7B4AA5A3-7508-4806-8D0D-2ED8CCA95730Q52849592-DF62C5A0-FF25-4D92-ADFF-3D6684786993
P2860
A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis
description
1992 nî lūn-bûn
@nan
1992 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
A double-blind, randomized, cr ...... ciated with multiple sclerosis
@ast
A double-blind, randomized, cr ...... ciated with multiple sclerosis
@en
A double-blind, randomized, cr ...... ciated with multiple sclerosis
@nl
type
label
A double-blind, randomized, cr ...... ciated with multiple sclerosis
@ast
A double-blind, randomized, cr ...... ciated with multiple sclerosis
@en
A double-blind, randomized, cr ...... ciated with multiple sclerosis
@nl
prefLabel
A double-blind, randomized, cr ...... ciated with multiple sclerosis
@ast
A double-blind, randomized, cr ...... ciated with multiple sclerosis
@en
A double-blind, randomized, cr ...... ciated with multiple sclerosis
@nl
P2093
P3181
P356
P1433
P1476
A double-blind, randomized, cr ...... ciated with multiple sclerosis
@en
P2093
P304
P3181
P356
10.1212/WNL.42.8.1468
P407
P577
1992-08-01T00:00:00Z